HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 288 filers reported holding HAEMONETICS CORP in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,604,965 | +1.3% | 96,059 | -3.7% | 0.06% | +7.7% |
| Q2 2023 | $8,496,121 | +1.1% | 99,790 | -1.7% | 0.05% | -5.5% |
| Q1 2023 | $8,401,442 | +4.4% | 101,528 | -0.8% | 0.06% | -1.8% |
| Q4 2022 | $8,047,704 | +4.0% | 102,323 | -2.1% | 0.06% | 0.0% |
| Q3 2022 | $7,740,000 | +10.3% | 104,555 | -2.9% | 0.06% | +19.1% |
| Q2 2022 | $7,019,000 | -0.1% | 107,684 | -3.1% | 0.05% | +23.7% |
| Q1 2022 | $7,024,000 | +17.5% | 111,100 | -1.4% | 0.04% | +26.7% |
| Q4 2021 | $5,977,000 | -26.3% | 112,688 | -1.9% | 0.03% | -30.2% |
| Q3 2021 | $8,105,000 | +2.9% | 114,818 | -2.8% | 0.04% | +59.3% |
| Q2 2021 | $7,873,000 | -23.4% | 118,149 | +27.6% | 0.03% | -25.0% |
| Q1 2021 | $10,278,000 | -6.1% | 92,586 | +0.4% | 0.04% | -12.2% |
| Q4 2020 | $10,946,000 | +34.1% | 92,175 | -1.4% | 0.04% | +5.1% |
| Q3 2020 | $8,160,000 | -3.9% | 93,525 | -1.3% | 0.04% | -4.9% |
| Q2 2020 | $8,490,000 | -33.4% | 94,799 | -25.9% | 0.04% | -41.4% |
| Q1 2020 | $12,748,000 | -14.1% | 127,914 | -0.9% | 0.07% | +22.8% |
| Q4 2019 | $14,833,000 | -8.8% | 129,096 | +0.1% | 0.06% | -13.6% |
| Q3 2019 | $16,262,000 | +2.5% | 128,917 | -2.2% | 0.07% | +6.5% |
| Q2 2019 | $15,859,000 | +35.7% | 131,787 | -1.3% | 0.06% | +40.9% |
| Q1 2019 | $11,683,000 | -15.8% | 133,547 | -3.7% | 0.04% | -22.8% |
| Q4 2018 | $13,869,000 | -12.7% | 138,625 | +0.0% | 0.06% | +7.5% |
| Q3 2018 | $15,883,000 | +27.3% | 138,621 | -0.4% | 0.05% | +23.3% |
| Q2 2018 | $12,475,000 | +395.2% | 139,108 | +304.0% | 0.04% | +377.8% |
| Q1 2018 | $2,519,000 | +2.6% | 34,433 | -18.5% | 0.01% | +12.5% |
| Q4 2017 | $2,455,000 | +31.8% | 42,271 | +1.8% | 0.01% | +14.3% |
| Q3 2017 | $1,863,000 | +20.2% | 41,528 | +5.8% | 0.01% | +16.7% |
| Q2 2017 | $1,550,000 | +23.5% | 39,254 | +26.9% | 0.01% | +20.0% |
| Q1 2017 | $1,255,000 | -16.9% | 30,940 | -17.7% | 0.01% | -16.7% |
| Q4 2016 | $1,511,000 | -99.9% | 37,581 | -1.3% | 0.01% | +20.0% |
| Q3 2016 | $1,378,732,000 | +25.0% | 38,076 | +0.0% | 0.01% | 0.0% |
| Q2 2016 | $1,103,359,000 | -18.8% | 38,060 | -2.0% | 0.01% | 0.0% |
| Q1 2016 | $1,359,000,000 | +13.6% | 38,844 | +4.7% | 0.01% | 0.0% |
| Q4 2015 | $1,196,000,000 | +100658.2% | 37,085 | +1.0% | 0.01% | 0.0% |
| Q3 2015 | $1,187,000 | -99.9% | 36,712 | +0.3% | 0.01% | -16.7% |
| Q2 2015 | $1,513,404,000 | -13.6% | 36,591 | -6.1% | 0.01% | -14.3% |
| Q1 2015 | $1,751,341,000 | +20.6% | 38,988 | +0.5% | 0.01% | +16.7% |
| Q4 2014 | $1,451,596,000 | +4.0% | 38,792 | -3.0% | 0.01% | 0.0% |
| Q3 2014 | $1,395,857,000 | -0.5% | 39,973 | +0.6% | 0.01% | 0.0% |
| Q2 2014 | $1,402,204,000 | +7.6% | 39,745 | -0.6% | 0.01% | 0.0% |
| Q1 2014 | $1,302,785,000 | -20.4% | 39,975 | +2.9% | 0.01% | -25.0% |
| Q4 2013 | $1,637,467,000 | +6.3% | 38,867 | +0.6% | 0.01% | 0.0% |
| Q3 2013 | $1,540,883,000 | -5.1% | 38,638 | -1.6% | 0.01% | -20.0% |
| Q2 2013 | $1,624,187,000 | – | 39,279 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |